Published in Ann Intern Med on April 01, 2014
Metabolically healthy overweight and obesity. Ann Intern Med (2014) 0.76
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med (2013) 9.66
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem (2003) 3.45
Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am J Clin Nutr (2007) 3.18
Barriers to physical activity among patients with type 1 diabetes. Diabetes Care (2008) 2.04
The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause (2012) 1.83
Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab (2007) 1.65
Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab (2004) 1.49
The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype. J Clin Endocrinol Metab (2014) 1.48
Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem (2003) 1.43
Effect of an Acute High Carbohydrate Diet on Body Composition Using DXA in Young Men. Ann Nutr Metab (2015) 1.38
Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism (2009) 1.32
Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) (2009) 1.30
Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr (2009) 1.30
Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Eur J Endocrinol (2006) 1.28
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25
Evaluation of the Portable HealthWear Armband: a device to measure total daily energy expenditure in free-living type 2 diabetic individuals. Diabetes Care (2005) 1.24
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24
Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev (2013) 1.22
Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes (2010) 1.21
Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes (2004) 1.15
Physical activity is a confounding factor of the relation between eating frequency and body composition. Am J Clin Nutr (2008) 1.15
Menopause and sarcopenia: A potential role for sex hormones. Maturitas (2011) 1.10
Targets for glycemic control. Can J Diabetes (2013) 1.09
Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors. Diabetes Technol Ther (2014) 1.07
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Diabetologia (2014) 1.06
Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res (2012) 1.06
Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation. J Clin Endocrinol Metab (2010) 1.04
Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study. Metabolism (2008) 1.01
Resistance training does not contribute to improving the metabolic profile after a 6-month weight loss program in overweight and obese postmenopausal women. J Clin Endocrinol Metab (2009) 1.00
Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study. J Am Diet Assoc (2009) 0.97
Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev (2009) 0.96
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol (2011) 0.96
Relationship between the body adiposity index and cardiometabolic risk factors in obese postmenopausal women. Eur J Nutr (2012) 0.94
Acute hyperglycemia induces a global downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects. Diabetes (2007) 0.93
To be obese--does it matter if you are metabolically healthy? Nat Rev Endocrinol (2011) 0.93
Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin. J Endocrinol (2006) 0.93
Pharmacokinetic analysis of absorption, distribution and disappearance of ingested water labeled with D₂O in humans. Eur J Appl Physiol (2011) 0.92
The metabolically healthy but obese postmenopausal woman presents a favourable heart rate variability profile. Scand Cardiovasc J (2011) 0.91
Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity (Silver Spring) (2008) 0.91
Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. J Clin Endocrinol Metab (2006) 0.90
The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) (2013) 0.89
Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab (2004) 0.89
Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus. Metabolism (2007) 0.89
CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells. PLoS One (2010) 0.89
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol (2011) 0.88
Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes. Diabetes Care (2013) 0.88
Effects of different types of exercise on body composition and fat distribution in HIV-infected patients: a brief review. Can J Appl Physiol (2005) 0.88
The Visceral Adiposity Index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women--a MONET group study. Appl Physiol Nutr Metab (2013) 0.88
Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: a pilot study. Schizophr Res (2013) 0.87
Test-retest reliability of a portable monitor to assess energy expenditure. Appl Physiol Nutr Metab (2011) 0.87
Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women. Metabolism (2008) 0.87
Effects of the addition of a resistance training programme to a caloric restriction weight loss intervention on psychosocial factors in overweight and obese post-menopausal women: a Montreal Ottawa New Emerging Team study. J Sports Sci (2010) 0.87
Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros (2007) 0.87
Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr (2007) 0.86
CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells. Am J Physiol Gastrointest Liver Physiol (2009) 0.86
Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing? Can J Cardiol (2013) 0.86
Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women. Appl Physiol Nutr Metab (2007) 0.85
Relationship between dynapenia and cardiorespiratory functions in healthy postmenopausal women: novel clinical criteria. Menopause (2011) 0.84
Change in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study. Clin Endocrinol (Oxf) (2008) 0.84
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. Obesity (Silver Spring) (2013) 0.83
Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation. J Diabetes Sci Technol (2013) 0.82
Resistance training attenuates fat mass regain after weight loss in ovariectomized rats. Maturitas (2009) 0.81
Under-utilization of capillary glucose monitoring by type 2 diabetic patients. Diabetes Res Clin Pract (2006) 0.81
Impact of the prorenin/renin receptor on the development of obesity and associated cardiometabolic risk factors. Obesity (Silver Spring) (2014) 0.80
Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus. Endocrinology (2010) 0.80
Relationship between long sleep duration and functional capacities in postmenopausal women. J Clin Sleep Med (2012) 0.80
Anthropometric, metabolic, psychosocial and dietary factors associated with dropout in overweight and obese postmenopausal women engaged in a 6-month weight loss programme: a MONET study. Br J Nutr (2009) 0.80
Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One (2013) 0.80
Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study. Eur J Endocrinol (2007) 0.79
Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss. Obesity (Silver Spring) (2011) 0.79
Obesity: Can inflammatory status define metabolic health? Nat Rev Endocrinol (2013) 0.79
Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study. Appl Physiol Nutr Metab (2007) 0.79
The degree of red blood cell aggregation on peripheral blood glass slides corresponds to inter-erythrocyte cohesive forces in laminar flow. Thromb Res (2004) 0.78
Female boxers have high bone mineral density despite low body fat mass, high energy expenditure, and a high incidence of oligomenorrhea. Appl Physiol Nutr Metab (2008) 0.78
Association between Abdominal Fat (DXA) and Its Subcomponents (CT Scan) before and after Weight Loss in Obese Postmenopausal Women: A MONET Study. J Obes (2011) 0.78
The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite (2012) 0.78
Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test? Appl Physiol Nutr Metab (2013) 0.78
Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Appl Physiol Nutr Metab (2009) 0.78
Impact of energy restriction with or without resistance training on energy metabolism in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team group study. Menopause (2013) 0.78
The Sedentary Time and Activity Reporting Questionnaire (STAR-Q): reliability and validity against doubly labeled water and 7-day activity diaries. Am J Epidemiol (2014) 0.77
Effects of tai chi training in dynapenic and nondynapenic postmenopausal women. Menopause (2011) 0.77
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study. J Phys Act Health (2014) 0.77
Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test: response to Abdul-Ghani et al. Diabetes Care (2007) 0.77